Trenabol Hexa 100 mg is an oil-based trenbolone hexahydrobenzylcarbonate injectable manufactured by British Dragon and dosed at 100 mg/mL in a 10 mL vial.
Trenabol Hexa 100 mg is an injectable anabolic-androgenic steroid containing trenbolone hexahydrobenzylcarbonate, a long-acting trenbolone ester. This compound was formerly marketed for human medical use in France under the brand names Parabolan and Hexabolan but has since been discontinued. It was introduced in 1980 and voluntarily taken off the market by its manufacturer in 1997. Trenbolone and its esters are now used primarily in veterinary medicine as implants for cattle to promote muscle growth and increase appetite.
In non-medical bodybuilding contexts, trenbolone hexahydrobenzylcarbonate is commonly referenced for its potent effects on body composition, similar to other trenbolone esters but with a longer release profile than the acetate version. Trenbolone binds to the androgen receptor with approximately three times the affinity of testosterone. It does not aromatize to estrogen, meaning it is not associated with estrogenic side effects such as gynecomastia or water retention. However, it is known for a distinctive side effect profile that may include insomnia, night sweats, increased aggression, and cardiovascular stress.
The hexahydrobenzylcarbonate ester provides a slower release of trenbolone compared to the acetate ester, allowing for less frequent administration. Once the ester is metabolized, the active compound is trenbolone. Historically, the clinical dosage was one ampoule containing 76 mg of the ester (equivalent to 50 mg of trenbolone base) every 10 days. Non-medical use of trenbolone falls outside approved indications and carries significant health risks.
Trenabol Hexa 100 mg uses MCT oil as its carrier oil, providing the oil base for the trenbolone hexahydrobenzylcarbonate formulation.
Trenbolone hexahydrobenzylcarbonate is a long-acting trenbolone ester that was formerly approved for human use under the brand name Parabolan. Its inability to aromatize and its high androgen receptor affinity are defining characteristics.
The hexahydrobenzylcarbonate ester is a long-acting prodrug of trenbolone. It is inactive until the ester group is cleaved in the bloodstream by plasma lipases, releasing the active hormone trenbolone. This enzymatic hydrolysis allows for a sustained release of trenbolone over an extended period.
The reported half-life of trenbolone hexahydrobenzylcarbonate varies across sources, with estimates ranging from 3–4 days to 5–7 days. Some sources reference an active life of approximately 9 days, noting that this is dose-dependent. This longer duration of activity compared to the acetate ester means less frequent injections are required.
Trenbolone itself is a potent androgen that does not aromatize to estrogen. It binds to the androgen receptor with approximately three times the affinity of testosterone. The ester primarily influences the rate of release and duration of activity rather than changing the underlying properties of trenbolone.
Trenbolone hexahydrobenzylcarbonate releases more gradually than trenbolone acetate due to its heavier ester. The clinical formulation of Parabolan delivered 50 mg of trenbolone base from 76 mg of the ester prodrug. This extended release profile allows for less frequent administration, typically once or twice weekly.
British Dragon offers several trenbolone formulations built around different esters and release profiles. The main practical distinction between these preparations is how quickly trenbolone is released and how long the formulation remains active after administration.
Hexahydrobenzylcarbonate is a longer-acting trenbolone ester. The Trenabol 100 provides a shorter-acting acetate alternative, while Trenabol Depot uses the enanthate ester. British Dragon also offers Trinabol, a multi-ester trenbolone formulation combining several release profiles.
The information below is provided for educational reference only. Trenbolone hexahydrobenzylcarbonate has not been approved by the FDA for human use. Non-medical use falls outside approved indications and carries significant health risks.
Historically, the clinical dosage of Parabolan was one ampoule containing 76 mg of trenbolone hexahydrobenzylcarbonate (equivalent to 50 mg trenbolone base) administered every 10 days. In non-medical bodybuilding contexts, trenbolone hexahydrobenzylcarbonate is commonly referenced in the range of 200–400 mg per week. Some sources reference effective doses of 300–500 mg per week. Because of its longer-acting ester, it is typically administered once or twice weekly. One professional bodybuilder disclosed using 350 mg per week during contest preparation, though he noted this is higher than he would recommend.
| Use Case | Common Reference Range | Injection Frequency |
|---|---|---|
| Clinical (historical) | 76 mg every 10 days | Per clinical protocol |
| Bodybuilding (non-medical, moderate) | 200–300 mg / week | Once or twice weekly |
| Bodybuilding (non-medical, experienced) | 300–400 mg / week | Twice weekly or split |
In non-medical bodybuilding contexts, trenbolone hexahydrobenzylcarbonate is often stacked with testosterone as a base compound. The "Test & Tren" stack is commonly referenced, with trenbolone at 200–400 mg per week alongside a testosterone base. British Dragon offers several testosterone preparations that are commonly referenced in this context, including Testabol Propionate and Testabol Enanthate.
Trenbolone is considered an advanced compound, and many resources emphasize that it should be used cautiously or not at all due to its significant side effect profile. Cycle duration is typically referenced as 6–8 weeks for trenbolone hexahydrobenzylcarbonate.
Trenbolone is known for a distinctive set of side effects that differ from many other anabolic steroids. Commonly reported effects include insomnia, night sweats, increased aggression, anxiety, and cardiovascular stress. These effects are often collectively referred to as "Tren sides" in bodybuilding communities.
Because trenbolone does not aromatize, aromatase inhibitors are not relevant for managing its side effects. Some users reference cabergoline for prolactin-related effects, though this should be based on bloodwork and medical guidance. Cardiovascular health, including lipid profiles, should be monitored during use. Parabolan is also noted for causing reduced HDL cholesterol and increased LDL cholesterol with excessive use.
After completing a cycle with Trenabol Hexa 100 mg, post-cycle therapy is commonly recommended to help restore endogenous testosterone production and support hormonal recovery. Agents such as Clomiphene and Tamoxifen are commonly referenced for this purpose.
Because trenbolone hexahydrobenzylcarbonate has a longer half-life than the acetate ester, it takes longer to clear from the system. PCT protocols vary based on cycle length, compounds used, and individual factors.
Dosing strategies, support compounds, and recovery protocols should be adjusted based on experience level and bloodwork where possible. The information above is for educational reference and does not constitute medical advice.
Trenbolone hexahydrobenzylcarbonate has not been approved by the FDA for human use. It is classified as a Schedule III controlled substance. Non-medical use carries significant health risks.
Trenbolone was formerly marketed for human medical use in France under the brand names Parabolan and Hexabolan but was voluntarily discontinued by its manufacturer in 1997. The FDA has approved trenbolone only as an implant for cattle to increase weight gain, and these products are explicitly labeled "Not for human use".
Anabolic steroids, including trenbolone, have not been shown to enhance athletic ability. Non-medical use of trenbolone hexahydrobenzylcarbonate falls outside approved indications and is associated with significant health risks.
Trenbolone has not been approved for human use. Product concentration and laboratory verification do not establish that non-medical use is safe or appropriate for an individual. The risks associated with trenbolone use are significant and may include cardiovascular, neurological, and hepatic effects.
Trenbolone is known for a distinctive side effect profile. Commonly reported effects include insomnia, night sweats, increased aggression, anxiety, and cardiovascular stress. These effects are often described as particularly intense compared to other anabolic steroids.
Anabolic steroids can affect lipid profiles, typically reducing HDL cholesterol and potentially increasing LDL cholesterol. Parabolan is noted for causing reduced HDL cholesterol and increased LDL cholesterol with excessive use.
Androgenic effects such as acne, oily skin, and hair loss in predisposed individuals can occur. Women may experience virilization symptoms including voice deepening, clitoral enlargement, and menstrual irregularities, and this drug should not be taken by females.
Trenbolone is also associated with a condition known as "Tren cough," which is a sudden and intense coughing fit that can occur after injecting the substance. This is due to the oil-based solution entering the bloodstream and irritating the lungs.
Trenbolone is not appropriate for individuals with certain medical conditions. Medical evaluation should precede any consideration of use, particularly for those with existing cardiovascular disease, liver conditions, or a history of hormone-sensitive cancers.
Pregnancy and breastfeeding are absolute contraindications. Women considering use should be aware of the potential for irreversible virilization effects.
Medically supervised anabolic steroid therapy involves regular monitoring of liver function, lipid profiles, and hormone levels. However, because trenbolone has not been approved for human use, there are no established monitoring protocols for its non-medical use. Bloodwork can help identify adverse changes, but the absence of monitoring significantly increases the risk of unrecognized adverse effects.
Keep the vial securely stored and protected from conditions that could compromise the product or container. Inspect the vial and solution before use and do not use a product that appears damaged, contaminated, or otherwise abnormal.
Keep all medications and injectable products out of the reach of children. Follow the storage instructions provided with the product packaging.
Trenabol Hexa 100 mg is supplied through the official British Dragon distribution chain and shipped in original manufacturer packaging with discreet, privacy-focused handling.
The outer shipping package remains discreet, with privacy-focused handling and no unnecessary external product details. Products are supplied through the official British Dragon distribution chain.
To verify your Trenabol Hexa 100 mg product, use the security features on the vial label and cross-check them with official British Dragon presentation. Genuine British Dragon vials typically feature specific label characteristics and packaging details that distinguish them from counterfeits.
For complete delivery details, tracking policy, and reshipment terms, please see our Shipping Info page.
Proper storage conditions help preserve formulation stability and overall product integrity throughout shelf life.
Store at controlled room temperature (15–25°C) and protect from excessive heat, moisture, and direct light. Maintaining stable conditions helps preserve the integrity of the oily formulation.
Keep the vial in its original packaging until use. Do not freeze. Before administration, inspect the solution and avoid use if it appears cloudy, discolored, contains particulate matter, or if the vial or seal is compromised.
Keep out of reach of children. Follow proper handling and sterile injection practices when administering the product.
Answers to common questions about Trenabol Hexa 100 mg, trenbolone hexahydrobenzylcarbonate, usage, and related topics.
Trenabol Hexa 100 mg contains trenbolone hexahydrobenzylcarbonate, an anabolic steroid that was formerly marketed for human use as Parabolan but discontinued in 1997. It is now used in veterinary medicine as a cattle implant. In non-medical bodybuilding settings, Trenabol Hexa 100 mg is commonly referenced for cutting and recomposition due to its potent effects, though such use falls outside approved indications and carries significant health risks.
Because of its long-acting hexahydrobenzylcarbonate ester, trenbolone hexahydrobenzylcarbonate is typically referenced as being administered once or twice weekly. Historically, the clinical dosage was one ampoule every 10 days. Injection frequency should be based on individual factors and experience level.
Trenbolone can suppress endogenous testosterone production. In non-medical bodybuilding contexts, post-cycle therapy is commonly referenced after a cycle to support hormonal recovery. Agents such as Clomiphene and Tamoxifen are commonly discussed for this purpose. Because trenbolone hexahydrobenzylcarbonate has a longer half-life, PCT may need to be delayed compared to shorter-acting trenbolone preparations.
Trenbolone hexahydrobenzylcarbonate is a long-acting ester of trenbolone, a potent anabolic steroid that binds to androgen receptors with approximately three times the affinity of testosterone. It does not aromatize to estrogen. Trenbolone is known for its strong effects on body composition and its distinctive side effect profile, which may include insomnia, night sweats, and cardiovascular stress.
Trenbolone hexahydrobenzylcarbonate has a longer half-life than the acetate ester, with estimates ranging from 3–4 days to 5–7 days. Some users report that it takes several weeks to notice effects, with one forum member noting it took 5–6 weeks to show itself. Cycle duration is typically referenced as 6–8 weeks.
Trenbolone is often described as extremely potent for body recomposition, but it is also associated with a significant side effect profile. Many resources emphasize that it should be used cautiously or not at all due to its risks. There is no single compound that is universally best, and suitability depends on individual goals and risk tolerance.
Trenabol Hexa 100 mg contains trenbolone hexahydrobenzylcarbonate, a longer-acting ester that requires less frequent injections. Trenabol 100 contains trenbolone acetate, a shorter-acting ester that is typically injected daily or every other day. The acetate version is often recommended for beginners because it clears the system more quickly if side effects occur.
Both are longer-acting trenbolone esters. Trenabol Hexa contains trenbolone hexahydrobenzylcarbonate, while Trenabol Depot contains trenbolone enanthate. The two esters have similar release profiles, with some sources noting that the hexahydrobenzylcarbonate ester has a half-life similar to enanthate.
A milligram amount cannot be classified as appropriate or excessive without considering individual factors, experience level, and side effect tolerance. In bodybuilding contexts, 200–300 mg per week falls within commonly referenced ranges for moderate use, but this does not establish that it is safe or appropriate for any individual. Non-medical use falls outside approved indications.
Trenabol Hexa 100 mg is labeled at 100 mg of trenbolone hexahydrobenzylcarbonate per mL. It is supplied in a 10 mL vial, giving 1,000 mg of total labeled trenbolone hexahydrobenzylcarbonate content per vial.
No. Trenbolone does not aromatize to estrogen, meaning it is not associated with estrogenic side effects such as gynecomastia or water retention. However, it is known for a different set of side effects that may include insomnia, night sweats, and cardiovascular stress.
Yes. Trenbolone is associated with a condition known as "Tren cough," which is a sudden and intense coughing fit that can occur after injecting the substance. This is due to the oil-based solution entering the bloodstream and irritating the lungs. While not life-threatening, it can be uncomfortable and alarming for users.